Market Access Advancements and Challenges in “Drug-Companion Diagnostic Test” Co-Development in Europe

The pharma ecosphere is witnessing a measured transformation from the one-size-fits-all or blockbuster model of drugs to more informed and tailored personalized treatments that facilitate higher safety and efficacy for a relevant sub-population. However, with several breakthroughs still in a nascent...

Descripción completa

Detalles Bibliográficos
Autores principales: Akhmetov, Ildar, Ramaswamy, Rakshambikai, Akhmetov, Illias, Thimmaraju, Phani Kishore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493497/
https://www.ncbi.nlm.nih.gov/pubmed/26075972
http://dx.doi.org/10.3390/jpm5020213
_version_ 1782379927722524672
author Akhmetov, Ildar
Ramaswamy, Rakshambikai
Akhmetov, Illias
Thimmaraju, Phani Kishore
author_facet Akhmetov, Ildar
Ramaswamy, Rakshambikai
Akhmetov, Illias
Thimmaraju, Phani Kishore
author_sort Akhmetov, Ildar
collection PubMed
description The pharma ecosphere is witnessing a measured transformation from the one-size-fits-all or blockbuster model of drugs to more informed and tailored personalized treatments that facilitate higher safety and efficacy for a relevant sub-population. However, with several breakthroughs still in a nascent stage, market access becomes a crucial factor for commercial success, especially when it comes to co-creating value for pertinent stakeholders. This article highlights diverse issues from stakeholder perspectives in Europe, specifically the ones which require immediate resolution. Furthermore, the article also discusses case studies articulating potential solutions for the issues discussed.
format Online
Article
Text
id pubmed-4493497
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-44934972015-07-07 Market Access Advancements and Challenges in “Drug-Companion Diagnostic Test” Co-Development in Europe Akhmetov, Ildar Ramaswamy, Rakshambikai Akhmetov, Illias Thimmaraju, Phani Kishore J Pers Med Review The pharma ecosphere is witnessing a measured transformation from the one-size-fits-all or blockbuster model of drugs to more informed and tailored personalized treatments that facilitate higher safety and efficacy for a relevant sub-population. However, with several breakthroughs still in a nascent stage, market access becomes a crucial factor for commercial success, especially when it comes to co-creating value for pertinent stakeholders. This article highlights diverse issues from stakeholder perspectives in Europe, specifically the ones which require immediate resolution. Furthermore, the article also discusses case studies articulating potential solutions for the issues discussed. MDPI 2015-06-12 /pmc/articles/PMC4493497/ /pubmed/26075972 http://dx.doi.org/10.3390/jpm5020213 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Akhmetov, Ildar
Ramaswamy, Rakshambikai
Akhmetov, Illias
Thimmaraju, Phani Kishore
Market Access Advancements and Challenges in “Drug-Companion Diagnostic Test” Co-Development in Europe
title Market Access Advancements and Challenges in “Drug-Companion Diagnostic Test” Co-Development in Europe
title_full Market Access Advancements and Challenges in “Drug-Companion Diagnostic Test” Co-Development in Europe
title_fullStr Market Access Advancements and Challenges in “Drug-Companion Diagnostic Test” Co-Development in Europe
title_full_unstemmed Market Access Advancements and Challenges in “Drug-Companion Diagnostic Test” Co-Development in Europe
title_short Market Access Advancements and Challenges in “Drug-Companion Diagnostic Test” Co-Development in Europe
title_sort market access advancements and challenges in “drug-companion diagnostic test” co-development in europe
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493497/
https://www.ncbi.nlm.nih.gov/pubmed/26075972
http://dx.doi.org/10.3390/jpm5020213
work_keys_str_mv AT akhmetovildar marketaccessadvancementsandchallengesindrugcompaniondiagnostictestcodevelopmentineurope
AT ramaswamyrakshambikai marketaccessadvancementsandchallengesindrugcompaniondiagnostictestcodevelopmentineurope
AT akhmetovillias marketaccessadvancementsandchallengesindrugcompaniondiagnostictestcodevelopmentineurope
AT thimmarajuphanikishore marketaccessadvancementsandchallengesindrugcompaniondiagnostictestcodevelopmentineurope

Ejemplares similares